Understand the Screening Lipid Panel diagnosis with this comprehensive guide. Learn about relevant healthcare terminology, clinical documentation requirements, and medical coding for lipid panel tests including cholesterol, triglycerides, HDL, LDL, and VLDL. Find information on normal ranges, abnormal results, and potential diagnosis implications. This resource helps healthcare professionals accurately document and code lipid panel screenings for optimal patient care and reimbursement.
Also known as
Encounter for screening for lipidemia
Routine lipid panel screening, no diagnosed dyslipidemia.
Pure hypercholesterolemia
Elevated cholesterol, may be identified via screening.
Pure hyperglyceridemia
Elevated triglycerides, may be found during screening.
Mixed hyperlipidemia
Elevated cholesterol and triglycerides, possibly from screening.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the lipid panel for routine screening?
When to use each related code
| Description |
|---|
| Screening Lipid Panel |
| Hyperlipidemia |
| Familial Hypercholesterolemia |
Using unspecified lipid panel codes when a more specific diagnosis is documented, leading to underpayment.
Billing individual lipid components separately when a panel code exists, causing overpayment and compliance issues.
Lack of documented medical necessity for the screening lipid panel, resulting in claim denials.
Patient presents for routine screening lipid panel as part of preventative cardiovascular health assessment. The patient reports no current symptoms of hyperlipidemia such as chest pain, shortness of breath, or extremity pain. Past medical history is significant for (insert relevant PMH, e.g., hypertension, diabetes, family history of hypercholesterolemia). Medications include (list current medications). Social history includes (document tobacco use, alcohol consumption, dietary habits, and exercise level). Physical examination reveals (document relevant findings, e.g., body mass index, blood pressure, heart rate, auscultation of heart and lungs). A fasting lipid panel was ordered to assess cholesterol levels, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Results will be reviewed upon receipt and discussed with the patient. Plan includes patient education regarding lifestyle modifications such as diet, exercise, and smoking cessation, if applicable. Pharmacological interventions such as statin therapy will be considered based on lipid panel results and cardiovascular risk factors. Follow-up appointment scheduled to review results and discuss management plan. ICD-10 code Z13.220, Encounter for screening for lipoid disorders, is documented for this preventative screening. CPT code 80061, Lipid Panel, will be billed for the laboratory services rendered.